The Mitochondrial CB1 Receptor: Where Cannabis Science Meets Brain Energy and Disease

The mitochondrial CB1 receptor (mtCB1R) regulates ATP production, calcium homeostasis, and neuronal signaling from within the mitochondria. It plays roles in learning, memory, and neuronal plasticity. Its involvement in bioenergetic failure makes it a potential target for preventing neuronal death in neurodegenerative and acquired brain diseases.

Narrative review synthesizing evidence on the endocannabinoid system with focus on the recently discovered mitochondrial CB1 receptor, its role in mitochondrial homeostasis, cognitive function, and neurodegeneration.

The discovery that CB1 receptors exist inside mitochondria — not just on cell surfaces — fundamentally changes our understanding of how cannabinoids affect the brain. This organelle-level receptor could be the key to cannabinoid-based neuroprotective therapies.

Mitochondrial dysfunction is the common thread in Alzheimer's, Parkinson's, stroke, and traumatic brain injury. A receptor that regulates mitochondrial function from within — and can be targeted by cannabinoids — represents a fundamentally new therapeutic concept.

mtCB1R research is still in early stages with many unknowns. Most evidence is from rodent models. The complexity of mitochondrial regulation means targeting mtCB1R could have unpredictable effects. Clinical translation is uncertain.